Diagnosis of hepatocellular carcinoma: Newer radiological tools

Seminars in Oncology

Volumn 39, Issue 4, 2012, Pages 399-409

  Lee, Jeong Min ^a   Yoon, Jeong Hee ^a   Kim, Kyung Won ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ECHO CONTRAST MEDIUM; FERUCARBOTRAN; GADOBENATE DIMEGLUMINE; GADOBUTROL; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; GADOXETIC ACID; PERFLUBUTANE; SHU 508; SONOVUE; SUPERPARAMAGNETIC IRON OXIDE;

BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTRAST ENHANCED ULTRASONOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAYSCALE ULTRASONOGRAPHY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; MICROBUBBLE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION COMPUTED TOMOGRAPHY; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MULTIDETECTOR COMPUTED TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84864458027     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2012.05.010     Document Type: Conference Paper

References (78)

1. P. Song, W. Tang, S. Tamura The management of hepatocellular carcinoma in Asia: a guideline combining quantitative and qualitative evaluation Biosci Trends 4 2010 283 287
2. M. Kudo, K.H. Han, N. Kokudo Liver Cancer Working Group report Jpn J Clin Oncol 40 Suppl 1 2010 i19 i27
3. S.H. Lee, H.C. Choi, S.H. Jeong Hepatocellular carcinoma in older adults: clinical features, treatments, and survival J Am Geriatr Soc 59 2011 241 250
4. M. Kudo Multistep human hepatocarcinogenesis: correlation of imaging with pathology J Gastroenterol 44 Suppl 19 2009 112 118
5. O. Matsui Detection and characterization of hepatocellular carcinoma by imaging Clin Gastroenterol Hepatol 3 2005 S136 S140
6. H.J. Yoo, J.M. Lee, M.W. Lee Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3.0T-MR imaging with pathologic correlation Invest Radiol 43 2008 538 546
7. B.I. Choi, J.M. Lee Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: Imaging diagnosis and staging of hepatocellular carcinoma J Hepatobiliary Pancreat Surg 2009
8. S.H. Yoon, J.M. Lee, Y.H. So Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation AJR Am J Roentgenol 193 2009 W482 W489
9. T.K. Kim, K.H. Lee, K. Khalili, H.J. Jang Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound Abdom Imaging 36 2011 244 263
10. J. Bruix, M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
11. A. Irshad, M. Anis, S.J. Ackerman Current role of ultrasound in chronic liver disease: surveillance, diagnosis and management of hepatic neoplasms Curr Probl Diagn Radiol 41 2012 43 51
12. J.Y. Lee, B.I. Choi, J.K. Han, J.M. Lee, S.H. Kim State-of-the-art ultrasonography of hepatocellular carcinoma Eur J Radiol 58 2006 177 185
13. K.S. Sodhi, R. Sidhu, M. Gulati Role of tissue harmonic imaging in focal hepatic lesions: comparison with conventional sonography J Gastroenterol Hepatol 20 2005 1488 1493
14. K.W. Kim, B.I. Choi, S.Y. Yoo Real-time compound ultrasonography: pictorial review of technology and the preliminary experience in clinical application of the abdomen Abdom Imaging 29 2004 491 497
15. S.H. Kim, J.M. Lee, K.G. Kim Comparison of fundamental sonography, tissue-harmonic sonography, fundamental compound sonography, and tissue-harmonic compound sonography for focal hepatic lesions Eur Radiol 16 2006 2444 2453
16. M. Omata, L.A. Lesmana, R. Tateishi Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma Hepatol Int 4 2010 439 474
17. T. Murakami, Y. Imai, M. Okada Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions Oncology 81 Suppl 1 2011 86 99
18. J. Bruix, M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
19. V. Santi, F. Trevisani, A. Gramenzi Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival J Hepatol 53 2010 291 297
20. A. Giorgio, G. Calisti, A. di Sarno Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound Anticancer Res 31 2011 3977 3982
21. T. Inoue, M. Kudo, O. Maenishi Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma AJR Am J Roentgenol 192 2009 698 705
22. S.H. Kim, J.M. Lee, J.Y. Lee Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis AJR Am J Roentgenol 184 2005 1077 1084
23. B.I. Choi Advances of imaging for hepatocellular carcinoma Oncology 78 Suppl 1 2010 46 52
24. F. Moriyasu, K. Itoh Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial AJR Am J Roentgenol 193 2009 86 95
25. A.P. Ayyappan, K.S. Jhaveri CT and MRI of hepatocellular carcinoma: an update Expert Rev Anticancer Ther 10 2010 507 519
26. C. Heilmaier, A.M. Lutz, N. Bolog Focal liver lesions: detection and characterization at double-contrast liver MR imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging Radiology 253 2009 724 733
27. M. Sherman Modern approach to hepatocellular carcinoma Curr Gastroenterol Rep 13 2011 49 55
28. N. Bolog, G. Andreisek, I. Oancea, A. Mangrau CT and MR imaging of hepatocellular carcinoma J Gastrointestin Liver Dis 20 2011 181 189
29. B.I. Choi, J.M. Lee Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: imaging diagnosis and staging of hepatocellular carcinoma J Hepatobiliary Pancreat Sci 17 2010 369 373
30. S.H. Kim, B.I. Choi, J.Y. Lee Diagnostic accuracy of multi-/single- detector row CT and contrast-enhanced MRI in the detection of hepatocellular carcinomas meeting the milan criteria before liver transplantation Intervirology 51 Suppl 1 2008 52 60
31. K.A. Miles, M.P. Hayball, A.K. Dixon Functional images of hepatic perfusion obtained with dynamic CT Radiology 188 1993 405 411
32. P.V. Pandharipande, G.A. Krinsky, H. Rusinek, V.S. Lee Perfusion imaging of the liver: current challenges and future goals Radiology 234 2005 661 673
33. V. Goh, Q.S. Ng, K. Miles Computed tomography perfusion imaging for therapeutic assessment: has it come of age as a biomarker in oncology? Invest Radiol 47 2012 2 4
34. L. Yu, X. Liu, S. Leng Radiation dose reduction in computed tomography: techniques and future perspective Imaging Med 1 2009 65 84
35. X. Liu, A.N. Primak, J.D. Krier Renal perfusion and hemodynamics: accurate in vivo determination at CT with a 10-fold decrease in radiation dose and HYPR noise reduction Radiology 253 2009 98 105
36. R. Goetti, S. Leschka, L. Desbiolles Quantitative computed tomography liver perfusion imaging using dynamic spiral scanning with variable pitch: feasibility and initial results in patients with cancer metastases Invest Radiol 45 2010 419 426
37. M.R. Meijerink, J.H. van Waesberghe, L. van der Weide Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases Eur Radiol 18 2008 2345 2354
38. V. Goh, M. Dattani, J. Farwell Radiation dose from volumetric helical perfusion CT of the thorax, abdomen or pelvis Eur Radiol 21 2011 974 981
39. K.A. Miles Perfusion CT for the assessment of tumour vascularity: which protocol? Br J Radiol 76 Spec No 1 2003 S36 S42
40. K.A. Miles, M.R. Griffiths Perfusion CT: a worthwhile enhancement? Br J Radiol 76 2003 220 231
41. D.V. Sahani, N.S. Holalkere, P.R. Mueller, A.X. Zhu Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue - initial experience Radiology 243 2007 736 743
42. K.A. Miles, C. Charnsangavej, F.T. Lee Application of CT in the investigation of angiogenesis in oncology Acad Radiol 7 2000 840 850
43. H.J. Jiang, Z.R. Zhang, B.Z. Shen Functional CT for assessment of early vascular physiology in liver tumors Hepatobiliary Pancreat Dis Int 7 2008 497 502
44. V. Goh, S. Halligan, C.I. Bartram Quantitative tumor perfusion assessment with multidetector CT: are measurements from two commercial software packages interchangeable? Radiology 242 2007 777 782
45. D. Ippolito, C. Capraro, A. Casiraghi, C. Cestari, S. Sironi Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging Eur Radiol 2011
46. D. Ippolito, S. Sironi, M. Pozzi Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization Eur J Radiol 73 2010 148 152
47. A.X. Zhu, N.S. Holalkere, A. Muzikansky, K. Horgan, D.V. Sahani Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma Oncologist 13 2008 120 125
48. M. Okada, T. Kim, T. Murakami Hepatocellular nodules in liver cirrhosis: state of the art CT evaluation (perfusion CT/volume helical shuttle scan/dual-energy CT, etc.) Abdom Imaging 36 2011 273 281
49. K.W. Kim, J.M. Lee, E. Klotz Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma Radiology 250 2009 425 434
50. K.W. Kim, J.M. Lee, J.H. Kim CT color mapping of the arterial enhancement fraction of VX2 carcinoma implanted in rabbit liver: comparison with perfusion CT AJR Am J Roentgenol 196 2011 102 108
51. S.E. Kang, J.M. Lee, E. Klotz Quantitative color mapping of the arterial enhancement fraction in patients with diffuse liver disease AJR Am J Roentgenol 197 2011 876 883
52. C.J. Zech, M.F. Reiser, K.A. Herrmann Imaging of hepatocellular carcinoma by computed tomography and magnetic resonance imaging: state of the art Dig Dis 27 2009 114 124
53. J.M. Lee, B.I. Choi Hepatocellular nodules in liver cirrhosis: MR evaluation Abdom Imaging 36 2011 282 289
54. J.M. Willatt, H.K. Hussain, S. Adusumilli, J.A. Marrero MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies Radiology 247 2008 311 330
55. Y.K. Kim, H.S. Kwak, C.S. Kim Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT Radiology 238 2006 531 541
56. H.J. Yoo, J.M. Lee, J.Y. Lee Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver Invest Radiol 44 2009 800 807
57. M. Di Martino, D. Marin, A. Guerrisi Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis Radiology 256 2010 806 816
58. G. Park, Y.K. Kim, C.S. Kim, H.C. Yu, S.B. Hwang Diagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine Br J Radiol 83 2010 1010 1016
59. S.H. Kim, S.H. Kim, J. Lee Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma AJR Am J Roentgenol 192 2009 1675 1681
60. H.Y. Sun, J.M. Lee, C.I. Shin Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or = 2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging Invest Radiol 45 2010 96 103
61. B. Taouli, R.L. Ehman, S.B. Reeder Advanced MRI methods for assessment of chronic liver disease AJR Am J Roentgenol 193 2009 14 27
62. B. Taouli, D.M. Koh Diffusion-weighted MR imaging of the liver Radiology 254 2010 47 66
63. T. Parikh, S.J. Drew, V.S. Lee Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging Radiology 246 2008 812 822
64. M. Bruegel, K. Holzapfel, J. Gaa Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique Eur Radiol 18 2008 477 485
65. K.W. Kim, J.M. Lee, B.I. Choi Assessment of the treatment response of HCC Abdom Imaging 2011
66. A. Luciani, A. Vignaud, M. Cavet Liver cirrhosis: intravoxel incoherent motion MR imaging - pilot study Radiology 249 2008 891 899
67. M. Lewin, L. Fartoux, A. Vignaud The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study Eur Radiol 21 2011 281 290
68. C.H. Thng, T.S. Koh, D.J. Collins, D.M. Koh Perfusion magnetic resonance imaging of the liver World J Gastroenterol 16 2010 1598 1609
69. H. Wang, G. Marchal, Y. Ni Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer World J Radiol 3 2011 1 16
70. R.K. Do, H. Rusinek, B. Taouli Dynamic contrast-enhanced MR imaging of the liver: current status and future directions Magn Reson Imaging Clin N Am 17 2009 339 349
71. S. Baxter, Z.J. Wang, B.N. Joe Timing bolus dynamic contrast-enhanced (DCE) MRI assessment of hepatic perfusion: Initial experience J Magn Reson Imaging 29 2009 1317 1322
72. M. Hagiwara, H. Rusinek, V.S. Lee Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging - initial experience Radiology 246 2008 926 934
73. T.S. Koh, C.H. Thng, P.S. Lee Hepatic metastases: in vivo assessment of perfusion parameters at dynamic contrast-enhanced MR imaging with dual-input two-compartment tracer kinetics model Radiology 249 2008 307 320
74. J.P. O'Connor, C.J. Rose, A. Jackson DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6 Br J Cancer 105 2011 139 145
75. J. Wang, L.T. Chen, Y.M. Tsang, T.W. Liu, T.T. Shih Dynamic contrast-enhanced MRI analysis of perfusion changes in advanced hepatocellular carcinoma treated with an antiangiogenic agent: a preliminary study AJR Am J Roentgenol 183 2004 713 719
76. C.Y. Hsu, Y.C. Shen, C.W. Yu Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil J Hepatol 55 2011 858 865
77. T. Yau, P.J. Chen, P. Chan Phase I dose-finding study of pazopanib in hepatocellular carcinoma: evaluation of early efficacy, pharmacokinetics, and pharmacodynamics Clin Cancer Res 17 2011 6914 6923
78. Y. Hirashima, Y. Yamada, U. Tateishi Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis Int J Cancer 2011